Please enable JS

YOU ARE

A STUDY COORDINATOR

Success is when the time to access an innovative treatment is reduced.

CT-SCOUT Solution ToTem4me Solution

Save time in your research activity

Thanks to CT-SCOUTTM you can identify the studies running at your site that could be worth considering for a patient. No need to know or remember all studies criteria: CT-SCOUTTM powerful algorithm will efficiently support you in identifying the potential appropriate studies. CT-SCOUTTM can also help you coordinate the research activities with your colleagues

The CT-SCOUT app

Our web and mobile application exclusively designed for investigators, with its easy-to-use questionnaire.

Why CT-SCOUT app ?

Free up your time

Minimize the administrative burden and redundancy that keeps you and your site staff from focusing on clinical research and patient care.

Involve more patients

Help your patients expand access to clinical trials by integrating CT-SCOUT

Stay Connected

Receive alerts when a patient is identified and track your patients in a decentralized manner

Testimonials

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,

Prof Laurent Peyrin-Biroulet
President, GETAID and ECCO

« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »

Prof Stéphane Nancey
Hepato-gastroenterology department,
Lyon-Sud University Hospital

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,

Prof Laurent Peyrin-Biroulet
President, GETAID and ECCO

LATEST NEWSOUR NEWS >

telemedecine technologies news

AI in medtech is taking off. Here are 4 trends to watch in 2025

January 30, 2025

MedtechDive Artificial intelligence was a topic of focus for the medical device industry in 2024. Companies including GE Healthcare, Medtronic and Dexcom touted new AI features, and others like Stryker and Quest Diagnostics added AI assets through M&A. Meanwhile, conversations about regulations and generative AI, models that are trained to create new data including images and text, dominated medtech conferences. The Food and Drug Administration recently […]

READ MORE
telemedecine technologies news

FDA Provides Guidance on Advanced Manufacturing Technologies Program

January 30, 2025

BioPharm International FDA published a final guidance on Jan. 2, 2025 for those interested in participating in the agency’s Advanced Manufacturing Technologies Designation Program, which was developed to facilitate drugs manufactured using advanced manufacturing technologies (AMTs). The guidance, Advanced Manufacturing Technologies Designation Program, is the final version of the draft document issued on Dec. 13, 2023. […]

READ MORE
telemedecine technologies news

New Data Links Decentralized Clinical Trial Approaches to Improved Diversity in Patient Populations

January 30, 2025

Applied Clinical Trials Online Medable has shared new data from the Tufts Center for the Study of Drug Development (CSDD)’s PACT Consortium linking decentralized clinical trial (DCT) approaches to a higher rate in participation across multiple demographic groups. The new research shows that a more strategic implementation of DCT elements, combined with increased regulatory oversight, […]

READ MORE